Advisor Partners’s Core Laboratories CLB Stock Holding History

Advisor Partners’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$235K	Sell	11,867 -237	-2%	-$6.3K	0.02%	719
2022 Q1	$383K	Sell	12,104 -90	-0.7%	-$2.52K	0.02%	602
2021 Q4	$273K	Sell	12,194 -957	-7%	-$25K	0.02%	707
2021 Q3	$365K	Sell	13,151 -845	-6%	-$25.7K	0.02%	573
2021 Q2	$545K	Buy	13,996 +177	+1%	+$6.34K	0.04%	475
2021 Q1	$398K	Buy	13,819 +239	+2%	+$8.16K	0.03%	545
2020 Q4	$360K	Sell	13,580 -1,292	-9%	-$26.4K	0.03%	541
2020 Q3	$227K	Sell	14,872 -412	-3%	-$8.64K	0.02%	599
2020 Q2	$311K	Buy	15,284 +3,538	+30%	+$63.4K	0.03%	511
2020 Q1	$121K	Buy	+11,746	New	+$329K	0.01%	577
2018 Q4	–	Sell	-1,926	Closed	-$223K	–	619
2018 Q3	$223K	Buy	1,926 +48	+3%	+$5.42K	0.03%	560
2018 Q2	$237K	Buy	+1,878	New	+$229K	0.04%	489

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advisor Partners's CLB Position: Q2 2022 in Review

Advisor Partners reduced its Core Laboratories (CLB) stake by 2% in Q2 2022, selling an estimated $6.3K and leaving 11,867 shares worth $235K. The position accounts for 0.02% of the portfolio, ranked #719.

Advisor Partners first reported a position in CLB in Q2 2018 and has held it in 12 quarters since. The position peaked at $545K in Q2 2021. 175 funds tracked by Wall St. Rank hold CLB as of Q2 2022.

Advisor Partners held 11,867 shares of Core Laboratories worth $235K as of Q2 2022.
Advisor Partners sold 237 Core Laboratories shares in Q2 2022, an estimated $6.3K.
Core Laboratories made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #719 holding.
Advisor Partners first reported a position in Core Laboratories in Q2 2018 and has held it in 12 quarters since.
Advisor Partners's Core Laboratories position peaked at $545K in Q2 2021.
175 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.